Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Brazil flag Brazil · Delayed Price · Currency is BRL
1.040
+0.010 (0.97%)
Sep 17, 2026, 5:05 PM GMT-3

BVMF:ONCO3 Financials Overview

Millions BRL. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,9905,7396,2275,4894,0882,702
Revenue Growth
-18.97%-7.83%13.45%34.26%51.30%32.77%
Gross Profit
1,3631,7862,0601,9291,452868.79
Operating Income
-2,040-1,365684.02769.67471.1177.22
Net Income
-4,230-3,624-646.19223.6246.26-46.9
Earnings Per Share
-4.87-4.18-1.050.420.09-0.11
EPS Growth
---379.95%--

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
113.46512.711,921761.421,0932,015
Total Debt
3,8803,8545,5934,5693,4882,438
Net Cash (Debt)
-3,766-3,342-3,673-3,808-2,395-423.3
Net Cash Growth
------
Net Cash Per Share
-4.34-3.86-5.96-7.11-4.50-1.03

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
309.59-118.63-184.85-51.56-271.64-9.28
Capital Expenditures
-131.92-168.12-214.25-311.7-300.18-201.95
Free Cash Flow
177.67-286.75-399.1-363.26-571.82-211.23
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
27.31%31.12%33.09%35.14%35.52%32.15%
Operating Margin
-40.88%-23.79%10.98%14.02%11.52%6.56%
Pretax Margin
-78.57%-55.10%-10.55%5.51%2.97%2.31%
Profit Margin
-84.77%-63.14%-10.38%4.07%1.13%-1.74%
FCF Margin
3.56%-5.00%-6.41%-6.62%-13.99%-7.82%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---29.5362.45-
Forward PE
28.5727.764.3719.4718.0622.45
PS Ratio
0.230.530.241.200.711.94